A_YNxsfdCpM https://histock.tw/talk/live.aspx?name=gtalk&id=1401 20260527 阿布波

台股 » 個股 » 浩鼎 » 籌碼相關 » 融資融券與借券

浩鼎

(4174)
可現股當沖
  • 股價
    28.65
  • 漲跌
    ▼0.80
  • 漲幅
    -2.72%
  • 成交量
    645
  • 產業
    上櫃 生技醫療類股
  • 228人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
浩鼎 (4174) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

浩鼎 (4174) 融資融券與借券

浩鼎 (4174) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
05/27-91,3544.12110000.0728.65-2.72%668
05/2601,3634.1400000029.45-2.97%793
05/25171,3634.1400000030.35-4.11%847
05/22391,3464.0900000031.65-2.31%667
05/21-131,3073.9700000032.40.15%256
05/2021,3204.0100000032.35-0.46%212
05/19-111,3184.0100000032.50.15%281
05/1871,3294.0400000032.45-0.15%288
05/1531,3224.0200000032.5-1.52%442
05/14-31,3194.01000000330.92%295
05/13-351,3224.02-30020.32032.7-0.30%634
05/12221,3574.13030.01000.2232.8-1.65%291
05/1111,3354.06030.01000.2233.35-2.06%368
05/08131,3344.06030.01000.2234.05-2.16%439
05/0721,3214.02030.0110.210.2334.8-1.28%478
05/06-781,3194.01030.01000.2335.251.15%2,038
05/05771,3974.25030.01000.2134.859.94%1,243
05/0471,3204.01030.01000.2331.7-0.47%345
04/3081,3133.99-230.01000.2331.850.16%355
04/29311,3053.97050.02000.3831.8-0.31%331
04/2861,2743.87050.02000.3931.9-0.47%485
04/27401,2683.85550.0210.090.3932.051.75%1,103
04/24531,2283.7300000031.5-4.26%974
04/23151,1753.5700000032.9-9.99%1,398
04/22231,1603.5300000036.55-0.27%240
04/21581,1383.4600000036.65-0.14%332
04/20351,0803.2800000036.7-3.29%695
04/17381,0453.1800000037.950.13%382
04/16441,0073.0600000037.9-0.79%371
04/1569632.9300000038.21.46%528
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
05/2701011@Limit202500251,22928.65-2.72%668
05/2600000@Limit205280441,20429.45-2.97%793
05/2500000@Limit20109401051,16030.35-4.11%847
05/2200000@Limit204350381,05531.65-2.31%667
05/2100000@Limit203200321,01732.40.15%256
05/2000000@Limit2023270-498532.35-0.46%212
05/1900000@Limit2022002298932.50.15%281
05/1800000@Limit2057005796732.45-0.15%288
05/1500000@Limit2025701891032.5-1.52%442
05/1400000@Limit20170017892330.92%295
05/13300-30@Limit201520015287532.7-0.30%634
05/1200003@Limit20.0123002372332.8-1.65%291
05/1100003@Limit20.0136003670033.35-2.06%368
05/0800003@Limit20.0149004966434.05-2.16%439
05/0700003@Limit20.0122002261534.8-1.28%478
05/0600003@Limit20.011100011059335.251.15%2,038
05/0500003@Limit20.0130003048334.859.94%1,243
05/0400003@Limit20.0110001045331.7-0.47%345
04/30200-23@Limit20.0125320-744331.850.16%355
04/2900005@Limit20.0227402345031.8-0.31%331
04/2800005@Limit20.0224002442731.9-0.47%485
04/2705055@Limit20.0249004940332.051.75%1,103
04/2400000@Limit20000035431.5-4.26%974
04/2300000@Limit2088008835432.9-9.99%1,398
04/2200000@Limit2014001426636.55-0.27%240
04/2100000@Limit2013001325236.65-0.14%332
04/2000000@Limit2055005523936.7-3.29%695
04/1700000@Limit20440018437.950.13%382
04/1600000@Limit2016001618437.9-0.79%371
04/1500000@Limit201000010016838.21.46%528
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
05/271664,789,4504,788,05024.84-8.43
05/261273,782,7503,785,50016.0221.65
05/251243,829,1003,818,65014.63-84.27
05/221083,442,5003,440,25016.2-20.83
05/21481,554,8501,555,50018.7513.54
05/20421,375,1501,370,85019.81-102.38
05/19581,903,8001,908,00020.6772.41
05/18792,549,6002,561,90027.42155.7
05/151274,199,0504,192,00028.75-55.51
05/14762,491,6002,506,35025.73194.08
05/131133,688,1503,726,80017.82342.04
05/12591,945,7501,944,60020.29-19.49
05/11923,099,3003,095,90025-36.96
05/08873,016,8503,002,85019.81-160.92
05/07782,739,0002,739,20016.312.56
05/0676327,156,50027,395,95037.44313.83
05/051414,704,0504,793,60011.34635.11
05/04812,593,7502,592,25023.47-18.52
04/30501,594,4501,604,35014.09198
04/29892,859,6002,862,00026.8826.97
04/281344,284,0004,296,25027.6691.42
04/2736712,239,20012,039,00033.28-545.5
04/241595,059,0505,058,05016.32-6.29
04/23441,523,0501,478,5503.15-1011.36
04/22371,356,3001,353,35015.44-79.73
04/2127993,200995,4508.1483.33
04/201114,129,8004,134,25015.9640.09
04/17612,330,5002,333,80015.9654.1
04/16813,100,9003,090,15021.83-132.72
04/151294,887,1004,910,00024.43177.52
浩鼎與中國博奧信仲裁案塵埃落定 博奧信確認須分攤ADC費用Anue鉅亨-2026/04/01
浩鼎轉投資潤雅生技疫苗佐劑報喜 獲美國FDA原料藥主檔案登記申請Anue鉅亨-2025/12/02
浩鼎 相關文章